Open AccessStimulation With 0.3-mg Recombinant Human Thyrotropin Prior to Iodine 131 Therapy to Improve the Size Reduction of Benign Nontoxic Nodular Goiter
Author(s) -
Viveque Egsgaard Nielsen,
Steen Joop Bonnema,
Henrik Boel-Jørgensen,
Peter Grupe,
László Hegedűs
Publication year - 2006
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.166.14.1476
Subject(s) - goiter , medicine , placebo , thyroid , endocrinology , context (archaeology) , recombinant dna , gastroenterology , pathology , chemistry , biology , biochemistry , paleontology , alternative medicine , gene
Use of recombinant human thyrotropin increases the thyroid radioiodine (iodine 131 [(131)I]) uptake and may have a role in the context of (131)I therapy of benign goiter.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom